NTLA
Intellia Therapeutics
biotech biofarmaceutici utilizzando editing genetico CRISPR
|
Statistiche PeriodoMax: 32.8 Min: 21.17 Δ/gg: 1.4 Vol Med: 1501618.48 Δ Period: -23.68% FTSE correlation: 0.19 |
|||||||||||
Delta a 1w 2024-04-18 (21.5): -1.53 Delta a 2w 2024-04-11 (24.95): -15.15 Delta a 1m 2024-03-26 (26.26): -19.38 Delta a 3m 2024-02-05 (24.84): -14.77 Delta a 6m 2023-11-07 (29.49): -28.21 Delta a 1Y 2023-05-17 (43.8): -51.67 | Registrati per appuntare delle note |